ATE121101T1 - Aus dalbaheptide hergestellte tetrapeptidantibiotika. - Google Patents

Aus dalbaheptide hergestellte tetrapeptidantibiotika.

Info

Publication number
ATE121101T1
ATE121101T1 AT91920590T AT91920590T ATE121101T1 AT E121101 T1 ATE121101 T1 AT E121101T1 AT 91920590 T AT91920590 T AT 91920590T AT 91920590 T AT91920590 T AT 91920590T AT E121101 T1 ATE121101 T1 AT E121101T1
Authority
AT
Austria
Prior art keywords
group
dalbaheptide
carboxyacid
tetrapeptide
aglucodalbaheptides
Prior art date
Application number
AT91920590T
Other languages
English (en)
Inventor
Adriano Malabarba
Romeo Ciabatti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE121101T1 publication Critical patent/ATE121101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91920590T 1990-12-10 1991-11-28 Aus dalbaheptide hergestellte tetrapeptidantibiotika. ATE121101T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90123672 1990-12-10

Publications (1)

Publication Number Publication Date
ATE121101T1 true ATE121101T1 (de) 1995-04-15

Family

ID=8204819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920590T ATE121101T1 (de) 1990-12-10 1991-11-28 Aus dalbaheptide hergestellte tetrapeptidantibiotika.

Country Status (10)

Country Link
EP (1) EP0561827B1 (de)
JP (1) JP3276632B2 (de)
KR (1) KR100202250B1 (de)
AT (1) ATE121101T1 (de)
CA (1) CA2098098C (de)
DE (1) DE69108930T2 (de)
DK (1) DK0561827T3 (de)
ES (1) ES2071346T3 (de)
IE (1) IE914265A1 (de)
WO (1) WO1992010517A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683881B2 (en) * 1993-05-19 1997-11-27 Vicuron Pharmaceuticals Inc. Synthetic aglucodalbaheptide antibiotics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2110401T3 (es) * 1989-07-18 1998-02-16 Biosearch Italia Spa Antibioticos pentapeptidicos derivados de dalbaheptidos.

Also Published As

Publication number Publication date
EP0561827A1 (de) 1993-09-29
JP3276632B2 (ja) 2002-04-22
WO1992010517A1 (en) 1992-06-25
CA2098098C (en) 2003-04-08
JPH06503307A (ja) 1994-04-14
EP0561827B1 (de) 1995-04-12
CA2098098A1 (en) 1992-06-10
KR930703358A (ko) 1993-11-29
DE69108930T2 (de) 1995-08-24
IE914265A1 (en) 1992-06-17
KR100202250B1 (ko) 1999-06-15
DE69108930D1 (de) 1995-05-18
ES2071346T3 (es) 1995-06-16
DK0561827T3 (da) 1995-07-03

Similar Documents

Publication Publication Date Title
ATE302180T1 (de) Zwischenprodukte zur herstellung von non-peptiden retroviralproteasehemmenden verbindungen
AU551463B2 (en) 2-oxoazetidine derivatives
DK0876388T3 (da) Tricykliske erythromycinderivater
IT7909592A0 (it) Procedimento per la produzione di un derivato n acilato selettivamente protetto di un antibiotico amino glicosidico
CA2021379A1 (en) Pentapeptide antibiotics derived from dalbaheptides
FI893842A0 (fi) Menetelmä uuden antibiootin, mersasidiinin, valmistamiseksi
DE69108930D1 (de) Aus dalbaheptide hergestellte tetrapeptidantibiotika.
ATE159533T1 (de) Syntetische aglukodalbaheptid-antibiotika
ES2121293T3 (es) Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.
ES2144271T3 (es) Sintesis de derivados de acido carboxilico.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
DE69116383D1 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung
ES2191778T3 (es) Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.
HUP9601528A2 (hu) Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
HUP9601525A2 (hu) Trombin- és Xa-faktor-gátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
KR940022256U (ko) 사출성형기용 셧 오프(Shut Off)식 노즐의 구조

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee